LifeSci Advisors News

Follow[dot]Health is a news alert service for Heathcare and Healthtech. We are following 40K entities across 30M news items - with 1M items added monthly. This is selected news for LifeSci Advisors, which is filed under Sectors / Healthtech. There are 1.2K news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
7/26/2022 Humacyte Preclinical Data on Small-Diameter Human Acellular
... applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. Humacyte Investor Contact: Joyce Allaire LifeSci Advisors LLC +1-617-435-6602 [email protected] [email protected] Humacyte Media Contact: [email protected] ...
Globe Newswire
7/25/2022 PolyPid Announces Presentation of Phase 2 D-PLEX‚ÇÅ‚ÇÄ‚ÇÄ Clinical Data at the Midwest Surgical Association 2022 Annual Meeting
... additional Company information, please visit https://www.globenewswire.com/Tracker?data=HPgJfqV2dXf6E_LCyI0wsBILsMoxhIPpxk8uIXFjUTuWIrCgkmnUTR9KcOH-YwNUtQDb5-0-VzLLdWiiRvfHGLou-YcUREGU0rd7YCwwsws= and follow us on [Twitter] and [LinkedIn] . Contacts: PolyPid Ltd. Ori Warshavsky COO ‚Äì US 908-858-5995 Investors: Bob Yedid LifeSci Advisors 646-597-6989 [email protected] Media Contact: Nechama Feuerstein 551-444-0784 [email protected] ...
Globe Newswire
7/25/2022 Motus GI Announces 1-FOR-20 Reverse Stock Split
... only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Investor Contact: Troy Williams LifeSci Advisors (518) 221-0106 [email protected] ...
Globe Newswire
7/25/2022 Aligos Therapeutics Initiates 12-Week Dosing Cohort in Phase 1b Study Evaluating Its Class II Capsid Assembly Modulator, ALG-000184 Globe Newswire
7/25/2022 Paratek Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022 Globe Newswire
7/22/2022 Pixium Vision announces its financial results for H1 2022 and provides a business update Globe Newswire
7/22/2022 DocGo to Exhibit Innovative Vehicles at 2022 Subway Series Mets vs. Yankees Game in NYC | Business Wire Business Wire
7/22/2022 ORYZON Reports Results and Corporate Update for Half-Year Ending June 30, 2022 Yahoo News
7/22/2022 ORYZON Reports Results and Corporate Update for Half-Year Globe Newswire
7/22/2022 DocGo to Exhibit Innovative Vehicles at 2022 Subway Series Mets vs. Yankees Game in NYC Business Wire
7/21/2022 OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET Globe Newswire
7/21/2022 Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial PR Newswire
7/21/2022 Motus GI to Release Second Quarter Results and Provide a Globe Newswire
7/21/2022 Motus GI Holdings (MOTS) Motus GI to Release Second Quarter Results and Provide a Business Update on August 11 researchpool.com
7/19/2022 HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition Globe Newswire
7/19/2022 Clene Receives Positive EMA Opinion on Orphan Drug Globe Newswire
7/19/2022 SCYNEXIS Presents Positive Data from Phase 3 CANDLE Nested Sub-Study Investigating Ibrexafungerp in Women with Recurrent Yeast Infections Who Failed Fluconazole During the ISSVD XXVI World Congress and International Vulvovaginal Disease Update Globe Newswire
7/19/2022 Capricor Therapeutics Announces First Patient Dosed in Pivotal Phase 3 Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy Globe Newswire
7/19/2022 Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease Globe Newswire
7/18/2022 HTG Molecular Diagnostics Announces Amendment to Senior Globe Newswire
7/14/2022 Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome Globe Newswire
7/14/2022 Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022 Globe Newswire
7/14/2022 TFF Pharmaceuticals Expands R&D Operations with New Austin Globe Newswire
7/13/2022 Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire
7/13/2022 scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion Globe Newswire